Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07222202 · ClinicalTrials.gov registry record · NA
Evaluation of Flexible Conductive Hearing Aids
A NA study of Conductive Hearing Loss, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT07222202 is a NA study of Conductive Hearing Loss that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07222202, a NA study of Conductive Hearing Loss, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Conductive hearing loss (CHL) is the most common type of hearing loss among the pediatric population. CHL occurs when sound is not properly transmitted from the external ear to the cochlea, and congenital pathologies like microtia/anotia, atresia, and absent or malformed ossicles make hearing loss permanent.
Conditions Studied
Interventions
- DEVICE flexible conductive hearing aid
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2026-01-14 |
| Est. Completion | 2027-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07222202
The ClinicalTrials.gov registry entry for NCT07222202 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Conductive Hearing Loss appearing as the primary indexed condition, and to 1 intervention - of which flexible conductive hearing aid is the first listed.
NCT07222202 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT07222202 about?
NCT07222202 is a clinical study titled "Evaluation of Flexible Conductive Hearing Aids". Conductive hearing loss (CHL) is the most common type of hearing loss among the pediatric population. CHL occurs when sound is not properly transmitted from the external ear to the cochlea, and congenital pathologies like microtia/anotia, atresia, and absent or malformed ossicles make hearing loss p...
What is the current status of trial NCT07222202?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2026-01-14. Estimated completion is 2027-11.
What conditions does trial NCT07222202 study?
This clinical trial studies the following conditions: Conductive Hearing Loss.
What interventions are being tested in trial NCT07222202?
The interventions under investigation include: flexible conductive hearing aid (DEVICE).
Who is sponsoring clinical trial NCT07222202?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07222202 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Conductive Hearing Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.